Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation
Coronavirus disease 2019 (COVID-19) has spread across the world, and no specific antiviral drugs have yet been approved to combat this disease. Favipiravir (FAV) is an antiviral drug that is currently in clinical trials for use against COVID-19. However, the delivery of FAV is challenging because of...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
American Chemical Society
2021
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111211154&doi=10.1021%2facs.molpharmaceut.1c00324&partnerID=40&md5=3655612691b6b95c38cbcb4ba55e84a2 http://eprints.utp.edu.my/32389/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|